Page last updated: 2024-08-26

propargylglycine and cardiovascular agents

propargylglycine has been researched along with cardiovascular agents in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bu, D; Du, J; Jin, H; Li, W; Ren, Y; Tang, C; Tang, X; Wang, Y; Wei, H; Zhao, X1

Other Studies

1 other study(ies) available for propargylglycine and cardiovascular agents

ArticleYear
Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:2

    Topics: Active Transport, Cell Nucleus; Alkynes; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body Weight; Cardiovascular Agents; Cells, Cultured; Cystathionine gamma-Lyase; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Foam Cells; Glycine; Humans; Hydrogen Sulfide; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; NF-kappa B; RNA, Messenger; Sulfides; Tumor Necrosis Factor-alpha

2009